MILESTONE PHARMACEUTICALS IN

Milestone Pharma (MIST) Slides to $0.70: Is This a Buying Opportunity?

Milestone Pharmaceuticals drops 3.3% to $0.70, near a 52‑week low and far below its 200‑day SMA—could be a value play for savvy investors seeking early‑stage cardiovascular breakthroughs.

MILESTONE PHARMACEUTICALS IN
Canada
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Samantha Roth

22/10/2026, 22:58

2 minutes to read

Milestone Pharmaceuticals Rallies 2.71% Amid Peer Declines, Eyes Heart‑Disease Innovation

Milestone Pharmaceuticals’ shares rally 2.71% amid modest peer movement—explore the latest price trend, valuation insights, and why it’s still a consolidation play.

MILESTONE PHARMACEUTICALS IN
Canada
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Jake Connors

22/10/2026, 00:20

3 minutes to read